Why You Should Add Haemonetics (HAE) to Your Portfolio Now [Yahoo! Finance]
Haemonetics Corporation (HAE)
Last haemonetics corporation earnings: 2/4 06:00 am
Check Earnings Report
US:NYSE Investor Relations:
phx.corporate-ir.net/phoenix.zhtml?c=72118&p=irol-irhome
Company Research
Source: Yahoo! Finance
The favorable prospects within the Plasma franchise also buoy optimism. The robust utilization of TEG disposables in the United States and China is driving revenues in Hemostasis Management, which is highly encouraging. Meanwhile, the impacts of economic uncertainties and foreign exchange remain concerns for the company's operations. In the past year, this Zacks Rank #2 (Buy) stock has rallied 1.2% compared with the 1.7% rise of the industry and a 25.1% increase of the S&P 500 composite. The global provider of blood and plasma supplies and services has a market capitalization of $4.38 billion. HAE surpassed estimates in each of the trailing four quarters, delivering an average earnings surprise of 15.99%. Let's delve deeper. Tailwinds Hospital Business Recovery Continues: Each of the four market-leading product lines within Haemonetics' hospital portfolio focuses on helping hospitals and clinicians provide the highest standard of patient care while simultaneously reducing
Show less
Read more
Impact Snapshot
Event Time:
HAE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
HAE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
HAE alerts
High impacting Haemonetics Corporation news events
Weekly update
A roundup of the hottest topics
HAE
News
- Global $3.9 Bn Apheresis Market Forecast to 2029: Surge in Use for Leukaemia and Paediatric Patients Boosts Growth Prospects [Yahoo! Finance]Yahoo! Finance
- Haemonetics Co. (NYSE: HAE) had its "outperform" rating re-affirmed by analysts at Barrington Research. They now have a $105.00 price target on the stock.MarketBeat
- Apheresis Market Worth $3.9 billion | MarketsandMarkets™ [Yahoo! Finance]Yahoo! Finance
- Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2024 Results: May 9, 2024 [Yahoo! Finance]Yahoo! Finance
- Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2024 Results: May 9, 2024PR Newswire
HAE
Earnings
- 2/8/24 - Beat
HAE
Sec Filings
- 4/17/24 - Form 4
- 4/1/24 - Form 8-K
- 3/13/24 - Form 4
- HAE's page on the SEC website